Reckitt, Watson Drop Patent In Suit Over Mucinex ANDA
By Allison Grande ( December 7, 2010, 2:48 PM EST) -- Reckitt Benckiser Inc. and Watson Pharmaceuticals Inc. have agreed to drop one of the two patents asserted in their dispute over Watson's attempt to make a generic version of the blockbuster cough treatment Mucinex....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.